Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • Applied Workflows with c-Myc tag Peptide: Protocols & Troubl

    2026-04-21

    Applied Workflows with c-Myc tag Peptide: Protocols & Troubleshooting

    Principle Overview: Leveraging the c-Myc tag Peptide in Research

    The c-Myc tag Peptide (SKU: A6003) from APExBIO is a synthetic peptide corresponding to the C-terminal residues (410–419) of human c-Myc, a transcription factor central to cell proliferation, apoptosis, and differentiation. In the laboratory, this reagent serves as a displacement agent for c-Myc-tagged fusion proteins bound to anti-c-Myc antibodies, enabling specific inhibition of antibody binding in immunoassays (source: product_spec). This precise displacement mechanism makes the c-Myc tag Peptide an indispensable control and optimization tool, especially in workflows that require high specificity and reproducibility, such as co-immunoprecipitation (Co-IP), Western blotting, and chromatin immunoprecipitation (ChIP).

    Beyond its displacement function, the c-Myc tag Peptide empowers researchers to dissect the regulatory balance between cell proliferation and apoptosis—hallmarks of oncogenic signaling—by modulating c-Myc activity and its interactions with key regulatory factors (source: resource_1).

    Step-by-Step Protocol Enhancements Using c-Myc tag Peptide

    Integrating the c-Myc tag Peptide into immunoassays is straightforward yet nuanced. Below, we break down a typical displacement workflow and highlight critical parameters for maximizing assay performance.

    1. Antibody Binding: Incubate lysates containing c-Myc-tagged fusion proteins with anti-c-Myc antibody-conjugated beads at 4°C for 1–2 hours with gentle rotation to ensure optimal binding (source: resource_2).
    2. Displacement Step: Add the c-Myc tag Peptide to the bead complex at a final concentration of 100–300 μg/mL, then incubate at room temperature (20–25°C) for 30 minutes. The peptide competes with the tagged protein for antibody binding, releasing the fusion protein into solution (source: resource_2).
    3. Elution and Analysis: Collect the supernatant containing the displaced fusion protein. Analyze by SDS-PAGE, Western blot, or downstream functional assays. For maximal recovery and minimal background, ensure thorough washing before and after displacement.

    For ChIP and other advanced workflows, the c-Myc tag Peptide can be used to specifically elute transcription factor complexes, preserving protein-DNA interactions critical for studying gene regulation mechanisms (source: resource_3).

    Protocol Parameters

    • assay | Peptide concentration | 100–300 μg/mL | Effective for displacing c-Myc-tagged fusion proteins from anti-c-Myc antibody beads in immunoprecipitation workflows | Ensures sufficient competition for antibody binding while minimizing excess peptide usage | resource_2
    • assay | Incubation temperature | 20–25°C | Applicable during the displacement step | Maximizes peptide activity and displacement efficiency without denaturing proteins | workflow_recommendation
    • assay | Solubility threshold in DMSO | ≥60.17 mg/mL | For preparing concentrated stock solutions before dilution in aqueous buffers | Ensures maximal solubility and stability of the peptide for consistent performance | product_spec

    Key Innovation from the Reference Study

    The study by Wu et al. (2021) (DOI:10.1080/15548627.2020.1761653) elucidates how selective autophagy tightly regulates transcription factor IRF3 by controlling its stability and, consequently, type I interferon production. This finding underscores the necessity of precise, controllable tools—such as the c-Myc tag Peptide—to modulate transcription factor–antibody interactions without disrupting broader signaling networks. By using the peptide as a displacement reagent, researchers can selectively interrogate protein complexes and post-translational modifications under immune-stimulatory or stress conditions, paralleling the study's approach to dissecting the dynamic regulation of transcription factors in innate immunity.

    Advanced Applications and Comparative Advantages

    The c-Myc tag Peptide stands out for its ultra-high purity (>99%) and robust solubility profile—soluble up to 60.17 mg/mL in DMSO and 15.7 mg/mL in water with ultrasonic treatment (source: product_spec). This enables precise titration and compatibility with high-sensitivity immunoassays. When compared to other tag peptides, such as FLAG or HA, the c-Myc tag Peptide demonstrates exceptional specificity for anti-c-Myc antibodies, minimizing cross-reactivity and background (source: resource_3).

    Its role extends beyond simple displacement: the peptide is a powerful tool for dissecting the balance of cell proliferation and apoptosis regulation, as it provides a means to specifically disrupt c-Myc–mediated interactions—integral for probing oncogenic signaling cascades (source: resource_1). For example, in studies of transcription factor regulation, the peptide enables selective elution and functional analysis of protein complexes, supporting mechanistic discoveries in cancer biology and immune modulation.

    Interlinking: Relationship to Existing Resources

    Troubleshooting and Optimization Tips

    Despite its robust design, several experimental pain points may arise when implementing the c-Myc tag Peptide. Here are actionable solutions, grounded in literature and workflow recommendations:

    • Incomplete Displacement: If tagged proteins are not fully released, increase the peptide concentration incrementally (by 50–100 μg/mL) or extend incubation to 45–60 minutes. Verify the solubility of your peptide stock; warming to room temperature and brief sonication can improve dissolution (source: product_spec).
    • Non-specific Binding or High Background: Thoroughly wash beads post-antibody binding and before peptide addition. Use low-salt wash buffers (e.g., 150 mM NaCl) to preserve specific interactions while minimizing background (source: resource_2).
    • Peptide Stability: Prepare fresh working solutions immediately prior to use. Store lyophilized peptide desiccated at -20°C to maintain purity and activity; avoid freeze-thaw cycles of peptide solutions (source: product_spec).
    • Solubility Issues in Water: When preparing aqueous stocks, use brief ultrasonic treatment to reach ≥15.7 mg/mL. Avoid ethanol as a solvent, as the peptide is insoluble in this medium (source: product_spec).

    Why this cross-domain matters, maturity, and limitations

    The intersection of transcription factor regulation and innate immune signaling, as highlighted by Wu et al. (2021), showcases the need for experimental tools like the c-Myc tag Peptide that allow selective probing of protein complexes without unintended disruption of broader signaling pathways (DOI:10.1080/15548627.2020.1761653). While the peptide is well-established for immunoassays and protein displacement, its application in dissecting immune regulatory mechanisms—such as those governing selective autophagy of transcription factors—remains an emerging frontier, requiring careful experimental validation and interpretation.

    Outlook: Next Steps for c-Myc Peptide-Enabled Research

    The c-Myc tag Peptide is poised to accelerate discoveries in cancer biology, immune regulation, and precision proteomics. As recent studies illuminate the dynamic regulation of transcription factors like IRF3 via selective autophagy, the ability to selectively manipulate protein complexes with synthetic peptides will become increasingly valuable for mapping functional outcomes in complex cellular contexts (DOI:10.1080/15548627.2020.1761653). The reagent's high purity, tailored solubility, and proven specificity position APExBIO's c-Myc tag Peptide as a benchmark tool for both foundational research and emerging translational applications.